ForePass endoscopic bypass device for obesity and insulin resistance—metabolic treatment in a swine model
Giulia Angelini(Università Cattolica del Sacro Cuore), Geltrude Mingrone(University of the Sacred Heart), Hobby Aggarwal(University of Gothenburg), Elena Previti(Università Cattolica del Sacro Cuore), Maria Emiliana Caristo(Università Cattolica del Sacro Cuore), Lisa Olsson(Wallenberg Wood Science Center), Elisa Pinheiro Ferrari(Universidade do Estado de Santa Catarina), Ivo Boškoski(Università Cattolica del Sacro Cuore), Manoel Galvão Neto(Orlando Health), Amalia Gastaldelli(National Research Council), Alfredo Genco(Sapienza University of Rome), Valentina Tremaroli(University of Gothenburg), Luca Proto(Agostino Gemelli University Polyclinic), Vincenzo Bove(Agostino Gemelli University Polyclinic), Stefan R. Bornstein(King's College London), Sara Russo(Università Cattolica del Sacro Cuore), Samantha Pezzica(Istituto di Fisiologia Clinica)
Cited by 8
Related Papers
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
|Diabetes Care|2022|1.9k
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
|The Journal of Clinical Endocrinology & Metabolism|2016|1.7k
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
|Nature Medicine|2017|1.6k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.5k